PREPL p.Pro243Ser
c.727C>T · rs760265313 · VCV1976490
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3963 | ambiguous |
|---|---|---|
| REVEL | 0.137 | moderately benign-leaning |
| SaProt | LLR -4.77 | tolerated |
| ⇒ REVEL and SaProt both call this tolerated; AlphaMissense is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 8.6 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 1.29 | unconstrained · MANE · 25 kb · p 1e-15 · regional, not allelic |
| Overall | ||
| CADD | 21.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P332S vs ClinVar P243S) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,400 |
| European (non-Finnish)grpmax | 0.00017% | 589,685 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PREPL
- Protein
- p.Pro243Ser
- Coding
- c.727C>T
- MANE Select
- NM_001171613
- dbSNP
- rs760265313
- Type
- single nucleotide variant
- Location
- chr2:44338512 (GRCh38)
- Gene constraint
- LOEUF 1.247 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 82.46 · 2 PDB
Disease context
myasthenic syndrome, congenital, 22 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Congenital myasthenic syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- PREPL p.Pro243Thr Uncertain significance ★ ⚠ same residue
- PREPL c.1262+1G>A Pathogenic/Likely pathogenic ★★ same condition
- PREPL c.1263-1G>C Pathogenic/Likely pathogenic ★★ same condition
- PREPL c.-49+1734C>T Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Arg206Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Gln14Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Gln456Ter Pathogenic/Likely pathogenic ★★ same condition
- PREPL p.Glu577Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prepl-p-pro243ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown